Overview

Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

Status:
Unknown status
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This is a pilot, single-center, interventional clinical trial in which subjects will receive 16 Gy of IRay treatment and Lucentis, followed by Lucentis treatment as needed.
Phase:
N/A
Details
Lead Sponsor:
Oraya Therapeutics, Inc.
Treatments:
Ranibizumab